ZLIRTLHEWY is a potent peptide CD47/SIRPα interaction inhibitor. ZLIRTLHEWY is promising for research of cancers [1].
References:
[1]. Zheng S, et al. Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions. Langmuir. 2023 Dec 12;39(49):18101-18112.
References:
[1]. Zheng S, et al. Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions. Langmuir. 2023 Dec 12;39(49):18101-18112.
















